Dailypharm Live Search Close

[Reporter¡¯s view] What was gained and lost with COVID R&D

By Kim, Jin-Gu | translator Alice Kang

22.05.23 06:00:30

°¡³ª´Ù¶ó 0



Literally, the companies have played it out to the end. By the companies, this reporter is referring to the developers of COVID-19 treatments and vaccines.

Just 2 years ago, the developers had received the investors¡¯ utmost interest. Stock prices soared when news broke out that a company is developing COVID-19 treatments or vaccines. The domestic stock market had been in a boom then, and every day, press releases on related news poured in. Some companies had even made malicious attempts to ride the investment boom.

Many new treatments and vaccines were released in the past 2 years, but many of the companies that attempted to develop COVID-19 treatments and vaccines have also waved the w

Kim, Jin-Gu(kjg@dailypharm.com)
If you want to see the full article, please JOIN US (click)